Consensus guidelines for anticardiolipin antibody testing

Thrombosis Research

Volumn 114, Issue 5-6 SPEC. ISS., 2004, Pages 559-571

  Wong, Richard C W ^a  

^a QUEENSLAND HEALTH   (Australia)

Author keywords

Antibody; Cardiolipin; Consensus; ELISA; Guideline; Phospholipid; Recommendation; Standardization

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PHOSPHOLIPID ANTIBODY;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; CALIBRATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; HUMAN; INCUBATION TIME; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; TEMPERATURE; THROMBOPHILIA;

EID: 7044272274     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.06.002     Document Type: Article

References (28)

1. Favaloro E.J., Wong R.C.W., Silvestrini R., et al. A multi-laboratory peer-assessment quality assurance program based evaluation of anti-cardiolipin and beta-2-glycoprotein-1 antibody assays. Semin. Thromb. Hemost. 2005;. [in press]
2. Wong R.C.W., Favaloro E.J., Pollock W., et al. A multi-centre evaluation of the intra-assay and inter-assay variation of commercial and in-house anti-cardiolipin antibody assays. Pathology. 36:2004;182-192
3. Harris E.N., Pierangeli S.S. Revisiting the anticardiolipin test and its standardization. Lupus. 11:2002;269-275
4. Favaloro E.J., Silvestrini R. Assessing the usefulness of anticardiolipin antibody assays: a cautious approach is suggested by high variation and limited consensus in multilaboratory testing. Am. J. Clin. Pathol. 118:2002;548-557
5. Roberts J.M., Macara L.M., Chalmers E.A., Smith G.C. Inter-assay variation in antiphospholipid antibody testing. BJOG. 109:2002;348-349
6. Tincani A., Allegri F., Sanmarco M., et al. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations-a cooperative project of the European Antiphospholipid Forum. Thromb. Haemost. 86:2001;575-583
7. Fontaine M., Homburger H.A., Nichols W.L. Persistent problems with standardization of immunoassays for anti-cardiolipin antibodies. Thromb. Haemost. 86:2001;1123-1124
8. Favaloro E.J., Silvestrini R., Mohammed A. Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approach. Pathology. 31:1999;142-147
9. Reber G., Arvieux J., Comby E., et al. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. The Working Group on Methodologies in Haemostasis from the GEHT (Groupe d'Etudes sur l'Hemostase et la Thrombose). Thromb. Haemost. 73:1995;444-452
10. Coulam C.B., McIntyre J.A., Wagenknecht D., Rote N. Interlaboratory inconsistencies in detection of anticardiolipin antibodies. Lancet. 335:1990;865
11. Wilson W.A., Gharavi A.E., Koike T., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 42:1999;1309-1311
12. Lockshin M.D., Sammaritano L.R., Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum. 43:2000;440-443
13. Passam F.H., Krilis S.A. Laboratory tests for the antiphospholipid syndrome: current concepts. Pathology. 36:2004;129-138
14. Giles I.P., Isenberg D.A., Latchman D.S., Rahman A. How do antiphospholipid antibodies bind beta2-glycoprotein I? Arthritis Rheum. 48:2003;2111-2121
15. Moons K.G.M., Grobbee D.E. When should we remain blind and when should our eyes remain open in diagnostic studies? J. Clin. Epidemiol. 55:2002;633-636
16. Swets J.A. Measuring the accuracy of diagnostic systems. Science. 240:1998;1285-1293
17. Ransohoff D.F., Feinstein A.R. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N. Engl. J. Med. 299:1978;926-930
18. Harris E.N., Gharavi A.E., Patel S., Hughes G.R.V. Evaluation of the anticardiolipin antibody test: report of an international workshop held April 4 1986. Clin. Exp. Immunol. 68:1987;215-222
19. Harris E.N. The second international anticardiolipin standardization workshop/the Kingston Antiphospholipid Antibody study (KAPS) group. Am. J. Clin. Pathol. 94:1990;476-484
20. Harris E.N., Pierangeli S.S., Birch D. Anticardiolipin wet workshop: Vth International Symposium on antiphospholipid antibodies. Am. J. Clin. Pathol. 101:1994;616-624
21. Pierangeli S.S., Stewart M., Silva L.K., Harris E.N. Report of an anticardiolipin wet workshop during the VIIth International Symposium on antiphospholipid antibodies. J. Rheumatol. 25:1998;156-162
22. Wong R.C.W., Wilson R.J., Pollock W., Steele R.H., Gillis D. Anti-cardiolipin antibody testing and reporting practices among laboratories participating in a large external Quality Assurance Program. Pathology. 36:2004;174-181
23. Ichikawa K., Khamashta M.A., Koike T., Matsuura E., Hughes G.R.V. Beta 2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. Arthritis Rheum. 37:1994;1453-1461
24. Ichikawa K., Tsutsumi A., Atsumi T., et al. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies. Arthritis Rheum. 42:1999;2461-2470
25. Greaves M., Cohen H., MacHin S.J., Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br. J. Haematol. 109:2000;704-715
26. Triplett D.A. Antiphospholipid antibodies. Arch. Pathol. Lab. Med. 126:2002;1424-1429
27. Wong R.C.W., Gillis D., Adelstein S., et al. Consensus Guidelines on Anti-Cardiolipin Antibody Testing and Reporting. Pathology. 36:2004;63-68
28. Cabral A.R., Cabiedes J., Alarcon-Segovia D. Tween 20 detaches cardiolipin from ELISA plates and makes anticardiolipin antibodies undetectable regardless of the presence of beta 2-glycoprotein-I. J. Immunol. Methods. 175:1994;107-114